Avid Bioservices Inc (CDMO)

[Carboat]

When Wolchok publicly mentions Bavi, we will be at $5.

A mention gives you a 10x increase in marketcap ...approaching $1b.

When the Duke paper hits, we're at $10.

A paper doubles that to almost $2b? No mentions or papers will matter much. They need results. And not early stage trial results but at least a large PII and even that will be met with great skepticism (which is appropriate given bavi/pphm poor track record).